Cargando…
MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells
BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of death from malignant tumors worldwide. More than 50% of HCC cases occur in China. The prognosis remains poor and overall efficacy is still unsatisfactory. Chemotherapy resistance is the most important reason for the poor outcom...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580351/ https://www.ncbi.nlm.nih.gov/pubmed/31235998 http://dx.doi.org/10.3748/wjg.v25.i22.2752 |